May 27, 2021 12:00 PM EDT
Coronavirus
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: WHO let­ter out­lines re­boot of IP shar­ing pro­gram; In­dia backs down on do­mes­ti­cal­ly-pro­duced vac­cine tri­al

Josh Sullivan

While vac­cine short­ages have kept many coun­tries in the midst of the pan­dem­ic, the World Health Or­ga­ni­za­tion is re­boot­ing its IP shar­ing scheme.

The Cos­ta …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Bio­phar­ma be­gins to con­tem­plate an RFK Jr.-in­flu­enced FDA if Trump wins

Pfiz­er shares new de­tails on obe­si­ty pipeline, hints at ‘oth­er op­por­tu­ni­ties’

GSK buys au­toim­mune T cell en­gager for $300M up­front from Chim­a­gen

No­var­tis takes $800M Mor­phoSys write­down mere months af­ter clos­ing ac­qui­si­tion

No­var­tis high­lights over­all M&A track record fol­low­ing Mor­phoSys im­pair­ment

Fol­low­ing March in­spec­tion, No­vo Nordisk's semaglu­tide man­u­fac­tur­ing fa­cil­i­ty cit­ed by FDA

A service from the Financial Times